Best Practice for the Administration of Daratumumab in Multiple Myeloma: Australian Myeloma Nurse Expert Opinion

• Príomhchruthaitheoirí: Tracy King (Údar), Jacqueline Jagger (Údar), Jodie Wood (Údar), Carmel Woodrow (Údar), Alicia Snowden (Údar), Sally Haines (Údar), Christina Crosbie (Údar), Kristen Houdyk (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Elsevier, 2018-01-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Patients with multiple myeloma (MM) are typically of an advanced age and may have significant co-existing medical conditions. They have often had multiple lines of therapy and as such experience disease-related effects alongside associated treatment toxicities. Daratumumab is a monoclonal antibody a...